$2.04
0.020.99%
Last update: Nov 10, 7:06 PM
Quantum BioPharma Ltd
QNTMNASDAQ
Quantum BioPharma fell 74.1% from $8.62 to $2.23, behind the S&P 500's +9.8%. Its worst day was Mar 11 (−25.0%), and its low came Mar 11 at $2.10.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Quantum BioPharma closed at its highest level of the year, 32.4% above where the year started.
+41.9% · S&P 500 +0.7%
Quantum BioPharma closed at its lowest level of the year, 75.6% below where the year started.
Story events cover the past 12 months · Times ET
−25.0%, the year's worst day · S&P 500 −0.1%
EPS of $-0.71 beat the $-0.93 estimate on $0.00 revenue (est. $1.2M).
+24.5% · S&P 500 −1.7%
Quantum BioPharma shares rose 23.3%, while the S&P 500 rose 0.2%.
+23.3% · S&P 500 +0.2%
EPS of $-3.06 missed the $-0.56 estimate on $0.00 revenue (est. $1.5M).
−5.1% · S&P 500 −0.3%
Quantum BioPharma shares fell 23.7%, while the S&P 500 rose 0.7%.
−23.7% · S&P 500 +0.7%
EPS of $-0.47 beat the $-0.51 estimate on $0.00 revenue.
+17.6% · S&P 500 −0.2%
Where it ended: a close of $2.23 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.63).
Nothing in the past 12 months.
All QNTM dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for QNTM and SPY from Benzinga historical bars. Not investment advice.
